Thermoreversible hydrogel-coated microneedles for dermal drug delivery

Joanna Hill-Tout, Derek Covill, Wing Man Lau, Keng Wooi Ng

Research output: Contribution to conferencePaperpeer-review


Drug-coated microneedle patches are a minimally invasive technique for dermal drug delivery. However, their formulation usually requires careful calibration of formulation viscosity to enable fluid flow through the coating equipment at a sufficiently low viscosity, yet promote bulk formation on the microneedle surface at a sufficiently high viscosity [1, 2]. Clearly, an ability to manipulate the viscosity of the coating formulation during the coating process will be advantageous. Here, we evaluate thermoreversible hydrogel formulations as a strategy to do so, using temperature as a trigger. Methylene blue (MB, 0.5% w/w) was formulated as a model drug in poloxamer 407 (15–28% w/w) hydrogels. Sol-gel transitions were determined using rotational rheometry. Cold liquid MB-poloxamer formulations were pipetted into microwells and warmed at 30°C until gelling. Polylactic acid microneedles were fabricated by micromoulding [3] and dipped into the gelling MB-poloxamer formulations. MB loading and in vitro release were quantified using UV/Vis spectrophotometry. Coated microneedles and MB release in excised porcine skin were visualised by light microscopy. The MB-poloxamer formulations underwent reversible sol-gel transitions between 10–25°C. MB incorporation did not alter the sol-gel transition temperatures of the hydrogels. The thermoreversibility of the formulations allowed facile loading in the microwell. Warming the formulations at 30°C rapidly increased their viscosities to promote bulk formation on the microneedle surface. Up to 2.5µg MB was loaded per 1cm2 microneedle patch. Whilst uncoated MB-poloxamer formulations exhibited extended release characteristics in vitro, coated formulations showed rapid release characteristics, probably due to the smaller bulk of the coating in the latter. The microneedles released MB within 15 min when inserted into porcine skin. Thermoreversible hydrogel formulations enable on-the-fly, temperature-controlled manipulation of formulation viscosity. This strategy can be used to formulate microneedle drug coatings for minimally invasive drug delivery in the skin.
Original languageEnglish
Number of pages1
Publication statusPublished - 11 Sept 2019
Event10th APS International PharmSci Conference - University of Grenwich, London, United Kingdom
Duration: 11 Sept 201912 Sept 2019
Conference number: 10


Conference10th APS International PharmSci Conference
Abbreviated titlePharmSci
Country/TerritoryUnited Kingdom
Internet address


Dive into the research topics of 'Thermoreversible hydrogel-coated microneedles for dermal drug delivery'. Together they form a unique fingerprint.

Cite this